Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?
05 Sep 2023
Combination treatment with pembrolizumab and lenvatinib appears to be a better option for patients with recurrent endometrial cancer (REC) or advanced endometrial cancer (AEC) with a platinum-free interval (PFI) of <6 months, suggests a recent study.
Is pembrolizumab-lenvatinib effective in recurrent endometrial cancer?
05 Sep 2023
Worsening kidney function ups ASCVD risk
05 Sep 2023
bởiStephen Padilla
Individuals with worsening kidney function are at greater risk of future atherosclerotic cardiovascular diseases (ASCVD), and such risk is more evident among women, according to a study.
